{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:52Z","timestamp":1783525912442,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sanofi-Genzyme"},{"name":"Shire-Takeda"},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.dld.2019.12.005","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T08:20:34Z","timestamp":1577953234000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement"],"prefix":"10.1016","volume":"52","author":[{"given":"Fabio","family":"Nascimbeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-1967","authenticated-orcid":false,"given":"Umberto","family":"Vespasiani Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-3923","authenticated-orcid":false,"given":"Francesco","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-3979","authenticated-orcid":false,"given":"Valerio","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0822-9673","authenticated-orcid":false,"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-0345","authenticated-orcid":false,"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.12.005_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mpd.2002.122394","article-title":"Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey","volume":"140","author":"Dionisi-Vici","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2019.12.005_bib0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.dld.2019.12.005_bib0015","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl Sci Rare Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0020","first-page":"72","article-title":"Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history","volume":"12 Suppl 1","author":"Baris","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.dld.2019.12.005_bib0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.dld.2019.12.005_bib0030","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75 Suppl 1","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.dld.2019.12.005_bib0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s12325-014-0174-0","article-title":"Management of bone disease in Gaucher disease type 1: clinical practice","volume":"31","author":"Giuffrida","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.dld.2019.12.005_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10245330500067181","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.dld.2019.12.005_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474086.2016.1112732","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"9","author":"Linari","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.dld.2019.12.005_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/diseases5010010","article-title":"The spectrum of neurological manifestations associated with Gaucher disease","volume":"5","author":"Roshan Lal","year":"2017","journal-title":"Diseases"},{"key":"10.1016\/j.dld.2019.12.005_bib0055","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.12.005_bib0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bcmd.2012.11.012","article-title":"Gammopathy and B lymphocyte clonality in patients with Gaucher type I disease","volume":"50","author":"Rodic","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcmd.2016.10.012","article-title":"Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease","volume":"68","author":"Nascimbeni","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10545-010-9070-1","article-title":"High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease","volume":"33","author":"Taddei","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.dld.2019.12.005_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2016.10.001","article-title":"Liver involvement in Gaucher disease \u2013 review and clinical approach","volume":"68","author":"Adar","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0016-5085(81)90202-X","article-title":"LIver abnormalities in patients with Gaucher\u2019s disease","volume":"80","author":"James","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.12.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057507","article-title":"Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage","volume":"8","author":"Bohte","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.12.005_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcmd.2016.12.010","article-title":"Are transient and shear wave elastography useful tools in Gaucher disease?","volume":"68","author":"Webb","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymgme.2018.08.004","article-title":"Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease","volume":"125","author":"Nascimbeni","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher\u2019s disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.dld.2019.12.005_bib0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10545-018-0142-y","article-title":"Hepatocellular carcinoma in Gaucher disease: an international case series","volume":"41","author":"Regenboog","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2018.08.004","article-title":"Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease","author":"Nascimbeni","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bcmd.2016.06.009","article-title":"Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease","volume":"60","author":"Regenboog","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0135","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.clinbiochem.2014.06.005","article-title":"Validity of beta-D-glucosidase activity measured in dried blood samples for detection of potential Gaucher disease patients","volume":"47","author":"Stroppiano","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dld.2019.12.005_bib0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0145","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.dld.2019.12.005_bib0150","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.dld.2019.12.005_bib0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bcmd.2016.10.002","article-title":"Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy","volume":"68","author":"Weinreb","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2019.12.005_bib0170","first-page":"S19","article-title":"Long-term treatment outcomes in Gaucher disease","volume":"90","author":"Charrow","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.dld.2019.12.005_bib0175","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.dld.2019.12.005_bib0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","article-title":"Complex lipid trafficking in Niemann-Pick disease type C","volume":"38","author":"Vanier","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0195","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2007-3016","article-title":"A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B","volume":"122","author":"McGovern","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2019.12.005_bib0200","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0210","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiol.2381041696","article-title":"Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing","volume":"238","author":"Mendelson","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2019.12.005_bib0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","article-title":"Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B","volume":"36","author":"Wasserstein","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types A and B Niemann Pick disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2019.12.005_bib0225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-Pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.dld.2019.12.005_bib0230","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2019.12.005_bib0235","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2019.12.005_bib0240","first-page":"117","article-title":"Cirrhosis and liver failure: expanding phenotype of Acid sphingomyelinase-deficient Niemann-Pick disease in adulthood","volume":"15","author":"Lidove","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.dld.2019.12.005_bib0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","article-title":"Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)","volume":"126","author":"Wasserstein","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M061978","article-title":"Evaluation of plasma cholestane-3beta,5alpha,6beta-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism","volume":"57","author":"Boenzi","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2019.12.005_bib0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cca.2018.08.039","article-title":"The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency","volume":"486","author":"Deodato","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dld.2019.12.005_bib0260","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/345074","article-title":"The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype\/phenotype correlations","volume":"71","author":"Simonaro","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.dld.2019.12.005_bib0265","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ejhg.2015.89","article-title":"Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann-Pick disease type B","volume":"24","author":"Acuna","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.dld.2019.12.005_bib0270","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","article-title":"Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months","volume":"41","author":"Wasserstein","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2018.09.028","article-title":"The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD","volume":"70","author":"Carter","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.12.005_bib0280","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman\u2019s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.12.005_bib0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency\u2014an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.dld.2019.12.005_bib0290","doi-asserted-by":"crossref","first-page":"429 e1","DOI":"10.1016\/j.medcli.2016.12.044","article-title":"Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management","volume":"148","author":"Camarena","year":"2017","journal-title":"Med Clin"},{"key":"10.1016\/j.dld.2019.12.005_bib0295","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0168-8278(00)80407-9","article-title":"Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer","volume":"32","author":"Elleder","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.12.005_bib0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0168-8278(99)80356-0","article-title":"Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation","volume":"31","author":"vom Dahl","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.12.005_bib0305","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.12.005_bib0310","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MPG.0b013e31828b36ac","article-title":"Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency","volume":"56","author":"Zhang","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2019.12.005_bib0315","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2559.2011.04164.x","article-title":"Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens","volume":"60","author":"Hulkova","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.dld.2019.12.005_bib0320","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/03007995.2017.1309371","article-title":"Progression of liver disease in children and adults with lysosomal acid lipase deficiency","volume":"33","author":"Burton","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dld.2019.12.005_bib0325","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2017.03.038","article-title":"Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: a nationwide multicentre cohort study","volume":"262","author":"Angelico","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dld.2019.12.005_bib0330","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ebiom.2015.05.018","article-title":"Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease","volume":"2","author":"Baratta","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.dld.2019.12.005_bib0335","doi-asserted-by":"crossref","first-page":"28014","DOI":"10.3390\/ijms161226085","article-title":"Does lysosomial acid lipase reduction play a role in adult non-alcoholic fatty liver disease?","volume":"16","author":"Baratta","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2019.12.005_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156113","article-title":"Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology","volume":"11","author":"Vespasiani-Gentilucci","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.12.005_bib0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061134","article-title":"A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease","volume":"18","author":"Tovoli","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2019.12.005_bib0350","article-title":"Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures","volume":"1864","author":"Gomaraschi","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.dld.2019.12.005_bib0355","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dld.2019.12.005_bib0360","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2011.11.004","article-title":"Structural bases of Wolman disease and cholesteryl ester storage disease","volume":"105","author":"Saito","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0365","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","article-title":"Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups","volume":"58","author":"Scott","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.12.005_bib0370","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.107.146639","article-title":"Prevalence of cholesteryl ester storage disease","volume":"27","author":"Muntoni","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dld.2019.12.005_bib0375","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13023-018-0768-8","article-title":"Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency","volume":"13","author":"Di Rocco","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2018.03.010","article-title":"Lysosomal acid lipase deficiency allograft recurrence and liver failure-clinical outcomes of 18 liver transplantation patients","volume":"124","author":"Bernstein","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0385","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.12.005_bib0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13023-017-0587-3","article-title":"Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study","volume":"12","author":"Jones","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.dld.2019.12.005_bib0395","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.dld.2019.12.005_bib0400","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2016.05.017","article-title":"Unique medical issues in adult patients with mucopolysaccharidoses","volume":"34","author":"Mitchell","year":"2016","journal-title":"Eur J Intern Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819309521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819309521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:44Z","timestamp":1761624764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819309521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1590865819309521"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.12.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}